Affordable cervical cancer prevention and diagnosis for women with HIV
The AVANÇO Research Consortium: A Mozambique/Brazil/Texas Alliance to advance novel and affordable technologies for the prevention and diagnosis of cervical cancer in women living with HIV
Brings together teams in Mozambique, Brazil, and Texas to create low-cost tools to prevent, find, and treat cervical cancer in women living with HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11400587 on NIH RePORTER |
What this research studies
You would be part of a program that builds clinics and research partnerships across Mozambique, Brazil, and the U.S. to test practical, low-cost ways to screen, diagnose, and treat cervical cancer in women with HIV. The consortium combines experts in HIV, cancer, engineering, pathology, and public health to design and pilot new technologies and workflows. Studies may include clinical screening, collection of samples, and testing devices or diagnostic methods in real-world clinics. The goal is sustainable methods that work in low- and middle-income settings and can be scaled up if successful.
Who could benefit from this research
Good fit: Women living with HIV—particularly those receiving care at participating sites in Mozambique, Brazil, or affiliated clinics—are the intended candidates for screening and diagnostic studies.
Not a fit: People without HIV, men, or women far from participating sites may not directly benefit from these specific studies.
Why it matters
Potential benefit: If successful, this work could make affordable screening and diagnostic tools more widely available to women with HIV, helping detect disease earlier and reduce deaths from cervical cancer.
How similar studies have performed: Some low-cost screening and HPV-testing approaches have shown promise in low-resource settings, but combining and implementing new technologies specifically for women living with HIV remains relatively novel.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Schmeler, Kathleen — University of Tx Md Anderson Can Ctr
- Study coordinator: Schmeler, Kathleen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.